Coronavirus LIVE Updates: 7th Assam MLA Tests Covid-19 Positive; DCGI Nod to Serum Institute of ...
(WorldNews India)

`The firm has to submit safety data, evaluated by the Data Safety Monitoring Board (DSMB), to the CDSCO before proceeding to phase 3 clinical trials,` a senior official said. `As per the study design, each subject will be administered two doses four weeks apart (first dose on day one and second dose on...